SEMINAR THEATRE PROGRAM 2026

* Program currently under update; content subject to change

4 Feb.
10:00-10:20 h.

Top Health & Nutrition Trends for 2026

As the global nutrition and wellness landscape continues to evolve, 2026 looks to be a year defined by nutrition innovations across a vast range of categories. However, some trends stand out from the rest, both in their veracity and potential market opportunities. Consumers continue to seek products that deliver tangible health benefits, align with ethical and environmental values, and offer convenient, science-backed solutions for daily wellbeing. In this presentation Innova Market Insights highlights 2026 health & nutrition trends, focusing on functional ingredients, personalized solutions, women’s health, and holistic mental wellbeing.

Enric Tardio Capdevila

Senior Business Development Managerr

Innova Market Insights

10:20-10:40 h.

Sepismart SR, sustained release for Nutrition

Sepismart SR is a synergistic co-granulated combinatio of Xhanthan and Acacia gums, processed without solvents. 100% from natural origin, it is an effective solution for clear-label dietary supplements. It has been precisely formulated in order to ensure an optimized performance, such as its demonstrated sustained release effect tested with different active ingredients: Caffeine, Melatonin, Vitamin C, Magnesium.

Micol Verlato

Marketing Project Manager

SEPPIC

10:40-11:00 h.

Afepadi Observatory: Medical Perception on the Use and Prescription of Food Supplements

We will present the latest findings from the Afepadi Observatory on the perception and recommendation of food supplements among Primary Care physicians in Spain. The study reveals a high level of recommendation, the importance of scientific evidence, and strong interest in further training, alongside barriers related to regulation, accessibility, and available information. This session will provide a clear overview of the key opportunities to strengthen the role of food supplements in clinical practice and public health.

Agustín Roqué

Secretario general de Afepadi

Afepadi

11:00-11:20 h.

New clinical applications of probiotics: mental health, fertility, oncology, chronic inflammation, and much more

Probiotics have moved beyond being a supplement solely associated with digestive health to become a tool with enormous therapeutic potential in multiple clinical areas. Scientific advances in recent years are expanding their role in addressing complex and highly prevalent diseases.\r\n\r\nIn this conference, we will explore the new clinical applications of probiotics, delving into their impact in areas such as mental health (gut-brain axis), fertility, oncology support, chronic inflammation, and other emerging areas with growing scientific evidence. We will address the mechanisms of action involved, the most studied strains, and the key criteria for proper selection and formulation.\r\n\r\nThis session is designed for professionals and brands seeking to update their knowledge, understand current market trends, and translate scientific evidence into innovative, effective, and successful products in the nutraceutical market.

José Manuel Mingot

Scientific Manager

KOROTT

11:20-11:40 h.

Ovoderm® WS, the perfect ally to promote skin longevity

Ovoderm® WS developed by Eggnovo is a hydrolyzed multi-collagen with elastin and HA. In this presentation, we will explain in detail how it is formed and absorbed in the body and present the studies that demonstrate its significant benefits both for the skin and at the capillary level. With 14 years of research and more than 20 studies, this unique active ingredient has been scientifically proven to restore the skin’s barrier function, improve hydration, reduce the main signs of skin aging and enhance capillary density. We will also highlight the new possibilities it offers in terms of formulation for oral solutions.

Leire Ojer Suzuki

Business Development Manager

Eggnovo

11:40-12:00 h.

Quatrefolic® PRO: The scientific evolution of bioavailable folate

Quatrefolic® PRO, the latest evolution in our line of (6S)-5-methyltetrahydrofolate, designed to take technical performance one step further.\r\nWith scientific validation complete, Quatrefolic® PRO has undergone exhaustive characterisation and stability testing, confirming its superior profile for advanced nutritional applications. The results validate its commercialisation with robust performance data.

Stefania Sala

Senior Product Manager Gnosis S.p.A.

IMPAG Iberia

12:00-12:20 h.

Redefining Water Retention Solutions with Elimreal®

Join this expert-led session exploring Elimreal®, a next-generation branded ingredient designed to support the elimination of excess water retention and bloating in nutraceutical formulations. Presented by Luis Serrano, PhD, the talk will examine the science behind Elimreal®, a synergistic blend of six botanicals, with a clear breakdown of its mechanism of action. Drawing on insights from our in-house R&D team, Dr. Serrano will highlight proven efficacy data and practical formulation applications. Attendees will learn how Elimreal® can drive meaningful product differentiation, improve formulation performance, and unlock new opportunities within the fluid-balance category. 

Luis Serrano

Senior Scientific Researcher

Natac Biotech S.L.U.

12:20-12:40 h.

WEIGHT LOSS COMPANIONS: LET THE NATURE SUPPORT YOUR BODY THROUGH THIS JOURNEY

With the rise of metabolic disorders and obesity, the use for GLP-1 agonists is increasing to target weight management, appetite control and blood glucose regulation, but their use can lead to unpleasant adverse events. Discover with us how the mindful use of innovative and well-documented natural ingredients can complement all the three phases (before, during, and after) of the GLP-1 journey.

Elisabetta Frattini

Jefa de comunicación científica y LCM

Indena

12:40-13:00 h.

From microbiome science to consumer value: unlocking the potential of Akkermansia

An introduction to The Akkermansia Company and its role in advancing next-generation microbiome solutions. The session explores the scientific origins of Akkermansia muciniphila and its evolution into a promising postbiotic innovation. Key concepts behind its mode of action, scientific insights, and potential relevance for metabolic health and weight management are addressed at a high level. Through expert perspectives and visual content, the session highlights how Akkermansia connects microbiome science with innovation and emerging opportunities in the health and nutrition space.

Maxime Daniel

Brand Manager

The Akkermansia Company

13:00-13:20 h.

Essential Oils in Microbiome Modulation: New Outstanding Evidence for Digestive Health

What if the key to restoring digestive balance were already tailored by nature and directly linked to the microbiome?\r\n\r\nBIOintestil® was formulated from this very question, offering a new perspective on digestive health: by reshaping the resident microbiota, it promotes balance and supports lasting gut wellness.\r\nDigestive disorders are increasingly complex, driven by modern lifestyle, stress, and habits that are in need of effective support. The human microbiota is a dynamic, evolving ecosystem, continuously shaped throughout life. When this delicate balance is disrupted, the effects extend far beyond the gut, influencing inflammation, metabolism, and even mood regulation.\r\n\r\nIn this talk, we explore the interaction between essential oils and the human microbiome, showing how the BIOintestil® patented formulation can exert multi-target biological activity, remodeling the resident microbiota and producing remarkable improvements in digestive function. This integrated action is driven by the unique chemical complexity of essential oils, acting simultaneously on microbial populations, inflammatory pathways, and intestinal barrier function.\r\n\r\nThe evidence comes from a robust scientific framework, including pharmacokinetic studies, preclinical research, and clinical investigation, featuring both a randomized, double-blind, placebo-controlled clinical trial and a real-life study on 1,585 patients from the BIOintestil® research line.\r\n\r\nJoin the speech for an in-depth scientific and technical exploration of this innovative approach and visit us at Booth E60 to discover the full microbiome modulators portfolio and the other products of our research line.

Marta Alberghini

Sales and Marketing Manager at TGD

Emgi srl

13:20-13:40 h.

Collagen Peptides and GLP-1: Innovation in metabolic wellness

The market for supplements, functional foods, and beverages is evolving, driven by consumers who are increasingly aware of their metabolic health. In this conference, you will learn about a specific collagen peptide composition targeting glucose control and the natural stimulation of GLP-1, which is key in regulating appetite, insulin secretion, and satiety. We will cover the science, mechanism of action, potential as a functional ingredient, and formulation possibilities to create innovative nutraceuticals that meet the demand for health and wellness solutions.

Florencia Moreno Torres

Global Marketing Manager

Rousselot

14.00 - 15.00 h

BREAK

15:00-15:20 h.

perFix® – Clinically Studied Persimmon Extract Supporting Healthy Body Composition

perFix®, the new extract from Euromed’s Mediterranean Extracts™ line, is a standardized persimmon fruit extract that has been clinically studied for its potential to support weight management and a healthy body composition.
In a 16-week randomized, double-blind, placebo-controlled study in overweight adults (18–65 years).

Euromed S.A.

15:20-15:40 h.

Evidence-based multi-ingredient solutions for cardiometabolic risk management

Cardiometabolic risk is a complex and multifactorial condition involving abdominal obesity, insulin resistance, lipid metabolism alterations, chronic inflammation, and intestinal and hepatic dysfunction. Addressing this complexity requires nutritional strategies capable of acting simultaneously on multiple physiological targets.\r\n\r\nThis talk will present multi-ingredient solutions developed by Eurecat, designed through rational combinations of bioactive compounds and metabolic cofactors, and supported by robust preclinical and clinical evidence. Results demonstrate significant improvements in key cardiometabolic risk parameters, including reductions in abdominal adiposity, improved insulin sensitivity, modulation of the gut microbiota, and improvements in markers related to liver function and metabolic inflammation.\r\n\r\nThe applicability of these solutions across different metabolic contexts will also be discussed, with particular attention to the perimenopausal transition and menopause, periods in which physiological changes may increase cardiometabolic risk. This approach highlights the potential of multi-ingredient formulations as innovative tools for the development of nutraceuticals targeting cardiometabolic health, with a clear translational and market-oriented perspective.

Katherine Gil

Innovation Manager

Eurecat, Centro Tecnológico de Catalunya

15:40-16:00 h.

Woman Health

Women are characterized by an extremely changing physiology linked to hormonal fluctuations throughout the different stages of their lives. These changes lead to significant variations at both the physical and psychological levels during the fertile stage. In addition, when estrogens levels decline, the risk of developing different types of diseases increases considerably, including infections, inflammatory conditions, early osteoporosis, metabolic syndrome, and neurological disorders.\r\nSabinsa, a leader in the development of natural active ingredients derived from Ayurvedic medicine, offers solutions designed to help stabilize vital parameters and promote women’s well-being, enabling them to feel good about themselves and their environment throughout their entire life cycle.

Aida María Arnaiz López

Sabinsa Sales and Marketing Consultant South of Europe

Sabinsa Europe GMbH

16:20-16:40 h.

AloeCell®️: Ultra-Pure Acemannan. Micro-Dose. Macro Impact..

AloeCell® is a next-generation functional ingredient based on ≥90% ultra-pure acemannan, the key bioactive polysaccharide of Aloe barbadensis. Unlike conventional aloe powders or low-grade mannans, AloeCell® is designed around purity, acetylation, and biological potency, enabling measurable effects at ultra-low dosages (3–10 mg).\r\nPeer-reviewed literature has demonstrated that acemannan plays a central role in intestinal barrier protection, microbiome modulation, immunomodulation, antioxidant defense, and tissue repair, acting through pathways such as MAPK, NF-κB, EGFR-related signaling, and mitochondrial ROS regulation. Recent in-vitro and ex-vivo models (including SHIME® gut fermentation systems and epithelial stress models) further support its ability to increase short-chain fatty acid production and to attenuate inflammatory and oxidative stress responses when administered continuously.\r\nFrom a formulation and commercial standpoint, AloeCell® offers high efficacy and regulatory compliant manufacturing at low entry points, allowing brands to achieve strong functional claims while maintaining cost efficiency, clean labels, and formulation flexibility across nutraceutical, cosmetic, and future medical-grade applications.

Henri Wagenbrenner

Business Development Manager

INQUIAROMA

5 Feb.
10:20-10:40 h.

Targeting Aging Hallmarks: Solutions for Brain and Lifespan.

Innovative ingredients that address the hallmarks of aging, support epigenetic health and help mantain cognitive function as we age.

Alice Olufeso

Senior Product Manager Food&Health

MIBELLE BIOCHEMISTRY

10:40-11:00 h.

Longevity.

UNDERSTANDING THE AGING PARADIGM\r\nThe aging process represents one of the most natural biological phenomena, characterized by progressive physiological decline and increased susceptibility to disease.\r\nSabina has examines the molecular mechanisms underlying aging, explores the concept of biomorphosis as a natural life transition, and evaluates evidence-based nutritional interventions that may support healthy aging and longevity.

Dr Umar Jahn

President European Operations

Sabinsa Europe GMbH

11:00-11:20 h.

FIBRIOTICS®AF+: Next-Generation Pre- & Postbiotics for Enhanced Microbiome Diversity – Beyond Traditional Prebiotics

Discover FIBRIOTICS®AF+, a revolutionary pre- and postbiotic formula that addresses the limitations of traditional prebiotics. Through our unique 4-stage fermentation process over 8 weeks, we transform 36 fermented fruits and vegetables enhanced with premium acacia fiber into a Low FODMAP solution that delivers >50% soluble microfibers from diverse fiber sources, bioactive polyphenols, preformed SCFAs, and postbiotics. Clinical evidence shows fermented foods significantly increase microbiome diversity while reducing inflammatory markers – without the bloating, cramping, or digestive discomfort associated with conventional prebiotics.\r\nDiscover how this ingredient, certified Low FODMAP™ by Monash University, provides superior support for gut health, with proven benefits for immunity, intestinal barrier function, and metabolic health, at a daily dose of just 500 mg.

Lydia Carrera

R&D Technologist – Natural Health division

FERMEDICS

11:40-11:20 h.

Sucrosomial® Technology: an innovative, patented system for the protection, transport, and absorption of minerals and vitamins.

Sucrosomial® Technology is a delivery system that not only protects essential nutrients such as minerals and vitamins within a phospholipid and sucrester matrix, but also transports them intact to the intestine, where absorption takes place. Scientific evidence supports improved absorption, efficacy, and tolerability of minerals thanks to this patented system.

Guillem Milà

Business Development Manager NATURAL HEALTH

PHARMANUTRA (TRADES)

12:00- 12:40 h.

Innovative dermoceutical solution for atopic-prone skin

Dermatidyss® is a nutraceutical ingredient that we have designed and developed at Abyss Ingredients for atopic-prone skin. This innovative ingredient goes beyond the traditional “beauty from within” trend, which is more focused on anti-ageing (anti-wrinkle, hydration, etc.), and addresses needs that have until now remained unmet: soothing both the skin and the mind of people suffering from atopic-prone skin through natural supplementation.

Hayza Cardoso

Sales Representative – Natural Health

Abyss Ingredients (TRADES)

12:40-13:00 h.

Fermented solution to enhance the link between digestive health and sports performance

Biotis® Fermentis is an innovative nutrition solution with triple action: high in protein and enriched with prebiotics and postbiotics to support digestive health and boost the performance of athletes and people who regularly consume protein.

Javier de Miguel

Product Manager – Sport Solutions

TRADES S.A.